Who owns VIVOS THERAPEUTICS INC?
- Ticker: VVOS
- CUSIP Number: 92859e207
Tip: Access positions for across all investors
Analyze quarterly positions in Vivos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Vivos Therapeutics stock
Who bought or sold VIVOS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Connective Capital Management | 200k | $620k | 100% | Sep 2025 |
|
| Strategic Wealth Designers | 100k | $310k | 100% | Sep 2025 |
|
| Vanguard Group | 92k | $284k | 115% | Sep 2025 |
|
| Geode Capital Management | 53k | $165k | -8% | Sep 2025 |
|
| National Asset Management | 44k | $135k | -37% | Sep 2025 |
|
| DRW Holdings | 42k | $129k | 100% | Sep 2025 |
|
| Commonwealth Equity Services | 41k | $127k | 0% | Sep 2025 |
|
| Renaissance Technologies | 39k | $122k | 100% | Sep 2025 |
|
| BlackRock | 28k | $86k | 100% | Sep 2025 |
|
| State Street Corporation | 25k | $77k | 111% | Sep 2025 |
|
| Northern Trust | 13k | $39k | 0% | Sep 2025 |
|
| Advisor Group Holdings | 6.6k | $21k | 726% | Sep 2025 |
|
| Tower Research Capital | 2.8k | $8.7k | 462% | Sep 2025 |
|
| Morgan Stanley | 1.1k | $3.4k | 100% | Jun 2025 |
|
| Signature | 547.00 | $1.7k | 0% | Sep 2025 |
|
| Ronald Blue Trust | 160.00 | $496.000000 | 0% | Sep 2025 |
|
| UBS Group | 102.00 | $315.996000 | -100% | Sep 2025 |
|
| Kozak & Associates | 49.00 | $117.002200 | 0% | Sep 2025 |
|
| FMR | 40.00 | $124.000000 | 100% | Sep 2025 |
|
| Global Retirement Partners | 23.00 | $71.001000 | 0% | Sep 2025 |
|
| Royal Bank of Canada | 4.00 | $0 | 0% | Sep 2025 |
|
Who sold out of Vivos Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Jun 2025 | 21k | $65k |
| Credit Agricole | Mar 2025 | 2.4k | $6.7k |
| Raymond James Financial | Jun 2025 | 74.00 | $234.002800 |
| Steward Partners Investment Advisory | Jun 2025 | 8.00 | $25.000000 |